Remote Therapeutic Monitoring to Support Adoption of Bispecific Antibody Therapy in Community Practices
Journal of Clinical Pathways · 01.06.2025 · 11 (3)
DOI: 10.25270/jcp.2025.05.02 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Pathways, online erschienen am 15.06.2025. Verfasst von James Essell und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Targeted therapies have transformed the cancer treatment landscape, marking a paradigm shift in cancer treatment. Bispecific antibodies (BsAbs), which engage two antigens simultaneously, represent the next advancement in targeted immuno-oncologic treatment. However, as treatment modalities become more sophisticated so do their associated toxicities, necessitating more time-intensive and specialized approaches to toxicity management. This results in increased efforts by clinics to monitor patients, particularly in the absence of trainees or specialized staff, further adding to the cost of care associated with such advanced treatments. Remote therapeutic monitoring (RTM) using electronic patient-reported outcomes (ePROs) is a key component to cost-effective toxicity management for promising drugs such as BsAbs. It may enable greater access to BsAbs by reducing the burden of otherwise manual patient monitoring and symptom management. This manuscript reviews the use of BsAbs, barriers to their adoption in community clinics, and how RTM can streamline and support patient management to improve patient outcomes and reduce the cost of adopting these novel treatments.
Zitieren
APA
Essell, J., Derman, B., Brooks, B., Doshi, G., Kolodziej, M., Kwiatkowsky, L., Calkins, G., & Ascha, M. (2025). Remote Therapeutic Monitoring to Support Adoption of Bispecific Antibody Therapy in Community Practices. Journal of Clinical Pathways, 11(3). https://doi.org/10.25270/jcp.2025.05.02
Vancouver
Essell J, Derman B, Brooks B, Doshi G, Kolodziej M, Kwiatkowsky L, et al. Remote Therapeutic Monitoring to Support Adoption of Bispecific Antibody Therapy in Community Practices. Journal of Clinical Pathways. 2025;11(3). doi:10.25270/jcp.2025.05.02
BibTeX
@article{Essell2025,
author = {Essell, James and Derman, Benjamin and Brooks, Barry and Doshi, Gurjyot and Kolodziej, Michael and Kwiatkowsky, Lavi and Calkins, Geoffrey and Ascha, Mustafa},
title = {Remote Therapeutic Monitoring to Support Adoption of Bispecific Antibody Therapy in Community Practices},
journal = {Journal of Clinical Pathways},
year = {2025},
volume = {11},
number = {3},
doi = {10.25270/jcp.2025.05.02}
}
EUVIMED